Here's Why Everyone's Talking About Iovance Biotherapeutics
Shares of Iovance Biotherapeutics (NASDAQ: IOVA) have been on a roller-coaster ride over the past few days. On May 18, Fardis notified the company she would be resigning "to pursue other opportunities." Iovance hasn't elaborated on the other opportunities Fardis will pursue, but they probably don't involve drug development.